Article
Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice.
American journal of physiology. Gastrointestinal and liver physiology - 1 Mar 2011
Csak Timea, Velayudham Arumugam, Hritz Istvan, Petrasek Jan, Levin Ivan, Lippai Dora, Catalano Donna, Mandrekar Pranoti, Dolganiuc Angela, Kurt-Jones Evelyn, Szabo Gyongyi
Abstract excerpt
Toll-like receptor 4 (TLR4) and its coreceptor, myeloid differentiation factor-2 (MD-2), are key in recognition of lipopolysaccharide (LPS) and activation of proinflammatory pathways. Here we tested the hypothesis that TLR4 and its coreceptor MD-2 play a central role in nonalcoholic steatohepatitis (NASH) and liver fibrosis in nonalcoholic fatty liver disease. Mice of control genotypes and those deficient in MD-2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
